Abiopharma

Energous Wireless Power Solutions Reports Third Quarter 2025 Results

Humacyte Announces Third Quarter 2025 Financial Results and Provides Business Update

Novocure to Participate in 2025 Jefferies Global Healthcare Conference

Beam Therapeutics to Participate in 2025 Jefferies London Healthcare Conference

Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results

AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy

CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension

Apellis Announces 5-Year GALE Data Showing SYFOVRE® (pegcetacoplan injection) Delayed Progression of Geographic Atrophy by ~1.5 Years

Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps